Resultados de la búsqueda 441-450 de 3819 para anti-TNF drugs
The purpose of this study is to test drug enfortumab vedotin in participants with a type of bladder cancer called non-muscle invasive bladder cancer (NMIBC) ...
Treatment for FSGS is considered unsuccessful if the patient is unresponsive to standard therapy (e.g., at least 8 weeks of corticosteroids) and fails to ...
Study of Adjuvant Cemiplimab Versus Placebo After Surgery and Radiation Therapy in Patients With High Risk Cutaneous Squamous Cell Carcinoma. Scottsdale/Phoenix ...
abril 2024. DEA Drug Take Back Day at Mayo Clinic in Florida April 23, 2024, 02:30 p.m. CDT · Mayo Clinic Minute: Creating an advance directive for your future ...
Niraparib in Combination With Trastuzumab in Metastatic HER2+ Breast Cancer. Rochester, Minn. The purpose of this study is to evaluate a new treatment using a ...
190 Second Street NW Rochester, MN 55901; Teléfono: 507-284-2511. Video thumbnail for Proton beam therapy at Mayo Clinic. 0:00. Off Air. / 4:03. Off; English.
... treatment, post-treatment and (when available) post-mortem soft tissue sarcoma (STS) tissue and tissue data with an emphasis on STSs occurring in younger ...
https://www.nimh.nih.gov/health/publications/depression/index.shtml. Accessed Aug. 13, 2019. Revisions to product labeling. U.S. Food and Drug Administration.
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?